This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sandoz Ag. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: William Lamanna: Innovator in Therapeutic Protein Purification
Introduction
William Lamanna is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of therapeutic applications through his innovative work on fusion proteins. With a total of 2 patents, Lamanna's inventions focus on improving the efficacy and purity of therapeutic proteins.
Latest Patents
One of Lamanna's latest patents is titled "Quantification of misfolded TNFR2:Fc." This invention is directed towards methods for determining the relative amount of wrongly disulphide bridged TNFR2:Fc in a sample. TNFR2:Fc is a fusion protein utilized in various therapeutic applications. The invention also includes a method for purifying TNFR2:Fc using the aforementioned quantification method, leading to improved TNFR2:Fc compositions.
Career Highlights
William Lamanna is currently associated with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His work at Sandoz AG has allowed him to focus on the development of innovative solutions in the field of biopharmaceuticals.
Collaborations
Throughout his career, Lamanna has collaborated with esteemed colleagues such as Alfred Rupprechter and Michael Fuchs. These collaborations have further enhanced his research and development efforts in therapeutic applications.
Conclusion
William Lamanna's contributions to the field of therapeutic protein purification exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements in the efficacy of therapeutic proteins.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile